[Show abstract][Hide abstract] ABSTRACT: Human immunodeficiency virus (HIV) affects an estimated 33 million people worldwide. Progression of the disease to acquired immunodeficiency syndrome (AIDS) is associated with compromised nutrition status and increased caloric needs. As the infection attacks and weakens the immune system, secondary opportunistic infections and malignancies often occur, which further compromise nutritional status and nutrient provision. One such condition is Kaposi sarcoma, an opportunistic malignancy examined in this case study. The patient, a young transgender male-to-female diagnosed with AIDS, presented with nausea, vomiting, and abdominal pain in November 2010. A gastric mass was discovered after an esophagogastro-duodenoscopy (EGD) was preformed and a subsequent biopsy diagnosed the patient with gastric Kaposi sarcoma. The position of the mass, coupled with the nutritional issues inherent with an AIDS diagnosis, complicated the provision of adequate nutrition with the patient. The medical nutrition therapy (MNT) included distal enteral nutrition, total parenteral nutrition, and oral intake as tolerated.
[Show abstract][Hide abstract] ABSTRACT: Since the advent of highly active antiretroviral therapy (HAART), the incidence of acquired immunodeficiency syndrome- (AIDS-) related Kaposi’s sarcoma (KS) has decreased dramatically. While cutaneous KS is the most common and well-known manifestation, knowledge of alternative sites such as the gastrointestinal (GI) tract is important. GI-KS is particularly dangerous because of its potential for serious complications including perforation, obstruction, or bleeding. We report a rare case of GI-KS presenting as upper GI bleeding in a human immunodeficiency virus- (HIV-) infected transgendered individual. Prompt diagnosis and early initiation of therapy are the cornerstones for management of this potentially severe disease.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.